Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Publications
Features
Glossary
Links
Quotations
References
About
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Publications
Features
Glossary
Links
Quotations
References
About
Blog
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Raymond March
-
September 12, 2018
Curing Diseases Is Sustainable, Government in Healthcare Is Not
If Telemedicine Is Underachieving, Government Is to Blame
When Healthy Policy Neglects Economic Principles, Patients Suffer
Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic
FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple...
Raymond March
-
September 26, 2018
0
FDA Still Hooked on Meddling in Nicotine Markets
Raymond March
-
October 8, 2018
0
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Raymond March
-
June 22, 2018
0
Right-to-Try Law Signed!
Raymond March
-
June 18, 2018
0
Three Reasons To Be Optimistic about Pharmaceutical Policy
Raymond March
-
August 2, 2018
0
Medical Apps: Improving Healthcare on a Global Scale
Raymond March
-
March 1, 2018
0
FDA Moves Closer to Approving Ecstasy
Raymond March
-
June 19, 2018
0
FDA Issues First Mandatory Recall for Contaminated Food
Raymond March
-
April 25, 2018
0
Open Up Off-Label Drug Communication and Let the Market Work!
Raymond March
-
August 7, 2018
0
FDA Considers Regulating E-cigarette Juices
Raymond March
-
September 1, 2018
0
1
2
3
Page 1 of 3
Edit with Live CSS
